Dapagliflozin Alters Plasma Metabolome in Patients With Type 1 Diabetes During Ketosis
Diabetes, Obesity and Metabolism · 2026-12 · 28 (12) · 11796-11807
DOI: 10.1111/dom.71390 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 28.09.2026. Verfasst von Rosa Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Metabolism, & Lipid Research, Washington University School of Medicine, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Benzhydryl Compounds, Glucosides, Metabolome. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, Washington University Diabetes Research Center, Washington University in St Louis Institute of Clinical and Translational Sciences.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
Use of sodium‐glucose cotransporter 2 inhibitors (SGLT2i) in patients with type 1 diabetes (T1D) is limited by increased risk of ketoacidosis. We aimed to determine metabolic pathways affected by SGLT2i treatment in adults with T1D during ketosis induced by insulin withdrawal. Materials and Methods Plasma metabolomic and lipidomic analysis by ultra‐high‐performance liquid chromatography/mass spectrometry was performed at baseline and after supervised insulin withdrawal in 17 adults with T1D treated with usual care (UC) and (DP) dapagliflozin (10 mg daily for 14 days).
Results
Plasma glucose levels were lower, and ketone levels were higher after insulin withdrawal in DP compared to UC. Pathway analysis of differentially altered metabolites revealed that DP altered amino acids and TCA cycle metabolites during ketosis. DP treatment increased citrate and aconitate at baseline, with a trend towards increased branched chain ketoacids and acylcarnitines. Citrate, aconitate, α‐ketoglutarate and malate were increased during insulin withdrawal after UC whereas insulin withdrawal after DP resulted in unchanged α‐ketoglutarate and malate and significantly decreased fumarate and succinate. Acetylcarnitine was significantly higher during insulin withdrawal after DP compared to UC. DP effected subtle changes in amino acids and amino acid derivatives. Symmetric dimethylarginine and pseudouridine were significantly elevated at baseline and after insulin withdrawal after DP. Lipidomics revealed increased very long TG species in DP and differences in phospholipids, particularly phosphatidylcholine.
Conclusion
In adults with T1D, dapagliflozin alters TCA cycle metabolites, amino acid metabolites and certain lipids during insulin withdrawal. Future work will validate findings and further investigate the metabolic basis of SGLT2i‐mediated ketoacidosis risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Metabolism, & Lipid Research, Washington University School of Medicine, St. Louis, Missouri, USA.
- Departments of Chemistry, Medicine, and the Center for Mass Spectrometry & Metabolic Tracing, Washington University School of Medicine, St. Louis, Missouri, USA.
- Division of Endocrinology & Metabolism, University of Virginia, Charlottesville, Virginia, USA.
ORCID-Profile: Max C Petersen, Samantha A DiGruccio
Förderung
- NIH HHS
- Washington University Diabetes Research Center
- Washington University in St Louis Institute of Clinical and Translational Sciences
- Breakthrough T1D
- NIDDK NIH HHS
- NCATS NIH HHS
- NHLBI NIH HHS
- National Institutes of Health
Zitieren
APA
Yang, R., Cho, K., Petersen, M. C., Jones, K. E., Patti, G. J., McGill, J. B., & DiGruccio, S. A. (2026). Dapagliflozin Alters Plasma Metabolome in Patients With Type 1 Diabetes During Ketosis. Diabetes, Obesity and Metabolism, 28(12), 11796-11807. https://doi.org/10.1111/dom.71390
Vancouver
Yang R, Cho K, Petersen MC, Jones KE, Patti GJ, McGill JB, et al. Dapagliflozin Alters Plasma Metabolome in Patients With Type 1 Diabetes During Ketosis. Diabetes, Obesity and Metabolism. 2026;28(12):11796-11807. doi:10.1111/dom.71390
BibTeX
@article{Yang2026,
author = {Yang, Rosa and Cho, Kevin and Petersen, Max C and Jones, Kai E and Patti, Gary J and McGill, Janet B and DiGruccio, Samantha A},
title = {Dapagliflozin Alters Plasma Metabolome in Patients With Type 1 Diabetes During Ketosis},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
volume = {28},
number = {12},
pages = {11796--11807},
doi = {10.1111/dom.71390}
}
EUVIMED